Z

Zyversa Therapeutics Inc
NASDAQ:ZVSA

Watchlist Manager
Zyversa Therapeutics Inc
NASDAQ:ZVSA
Watchlist
Price: 1.26 USD -3.08% Market Closed
Market Cap: 1.3m USD
Have any thoughts about
Zyversa Therapeutics Inc?
Write Note

Zyversa Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zyversa Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zyversa Therapeutics Inc
NASDAQ:ZVSA
Tax Provision
$9.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Tax Provision
-$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$63m
CAGR 3-Years
68%
CAGR 5-Years
48%
CAGR 10-Years
30%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$449m
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$739.4m
CAGR 3-Years
-9%
CAGR 5-Years
-31%
CAGR 10-Years
-61%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$314.9m
CAGR 3-Years
33%
CAGR 5-Years
-20%
CAGR 10-Years
3%

See Also

What is Zyversa Therapeutics Inc's Tax Provision?
Tax Provision
9.5m USD

Based on the financial report for Dec 31, 2023, Zyversa Therapeutics Inc's Tax Provision amounts to 9.5m USD.

What is Zyversa Therapeutics Inc's Tax Provision growth rate?
Tax Provision CAGR 1Y
1 169%

Over the last year, the Tax Provision growth was 1 169%.

Back to Top